Novo Nordisk’s next-generation obesity treatment shows promise in early study The study tested an injectable form of the drug, amycretin. Novo is also developing a pill form

https://www.statnews.com/2025/01/24/novo-nordisk-amycretin-injectable-trial-wegovy/?utm_campaign=daily_recap&utm_medium=email&_hsenc=p2ANqtz--Z85rg6FzUw1hApF760R_YzmIDj1ie_7Ff8Soc_cAMNIor4dS6m-dWYqMMjcmyeR2zYoFs3_3ixwLAzRQEt9E2Skw3dw&_hsmi=344051288&utm_content=344051288&utm_source=hs_email